Related Experiment Videos
Lipid-lowering drugs: who gets what?
P N Durrington1, R Illingworth
1University of Manchester Department of Medicine, Manchester Royal Infirmary, UK.
Current Opinion in Lipidology
|September 18, 1998
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Scintillation light detection in the 6-m drift-length ProtoDUNE Dual Phase liquid argon TPC.
The European physical journal. C, Particles and fields·2022
Prospects for beyond the Standard Model physics searches at the Deep Underground Neutrino Experiment: DUNE Collaboration.
The European physical journal. C, Particles and fields·2021
Measurement of the Effective Weak Mixing Angle in pp[over ¯]→Z/γ^{*}→ℓ^{+}ℓ^{-} Events.
Physical review letters·2018
Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.
Current opinion in lipidology·2026
The role of metabolic profiling and dietary intervention in the early diagnosis and prevention of atherosclerosis.
Current opinion in lipidology·2026
Inflammation and atherosclerotic cardiovascular disease: where do we go from here?
Current opinion in lipidology·2026
HDL and ASCVD: is high HDL-C protective, harmful, or simply misleading?
Current opinion in lipidology·2026
Analysis of the efficacy and safety of liraglutide, semaglutide, and tirzepatide for the treatment of overweight and obesity: a systematic review and network meta-analysis.
Journal of endocrinological investigation·2026
Pneumocephalus after deep brain stimulation in Parkinson's disease: The role of brain volume in brain shift.
Surgical neurology international·2026
Investigating the Antidiabetic Effects of Calotropis procera: Preclinical Assessment.
Food science & nutrition·2026
Drug-associated psoriasis: a pharmacovigilance study based on the FAERS database.
Frontiers in pharmacology·2026